JP2022525164A5 - - Google Patents
Info
- Publication number
- JP2022525164A5 JP2022525164A5 JP2021555282A JP2021555282A JP2022525164A5 JP 2022525164 A5 JP2022525164 A5 JP 2022525164A5 JP 2021555282 A JP2021555282 A JP 2021555282A JP 2021555282 A JP2021555282 A JP 2021555282A JP 2022525164 A5 JP2022525164 A5 JP 2022525164A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antibody
- concentration
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025002888A JP2025061116A (ja) | 2019-03-14 | 2025-01-08 | 遺伝性血管性浮腫の発作を処置するための血漿カリクレイン阻害剤およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962818189P | 2019-03-14 | 2019-03-14 | |
| US62/818,189 | 2019-03-14 | ||
| PCT/US2020/022535 WO2020186132A1 (en) | 2019-03-14 | 2020-03-13 | Treating hereditary angioedema attack with reduced dosage of antibodies binding to human plasma kallikrein |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025002888A Division JP2025061116A (ja) | 2019-03-14 | 2025-01-08 | 遺伝性血管性浮腫の発作を処置するための血漿カリクレイン阻害剤およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525164A JP2022525164A (ja) | 2022-05-11 |
| JP2022525164A5 true JP2022525164A5 (https=) | 2023-03-20 |
Family
ID=70228815
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555282A Pending JP2022525164A (ja) | 2019-03-14 | 2020-03-13 | 遺伝性血管性浮腫の発作を処置するための血漿カリクレイン阻害剤およびその使用 |
| JP2025002888A Pending JP2025061116A (ja) | 2019-03-14 | 2025-01-08 | 遺伝性血管性浮腫の発作を処置するための血漿カリクレイン阻害剤およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025002888A Pending JP2025061116A (ja) | 2019-03-14 | 2025-01-08 | 遺伝性血管性浮腫の発作を処置するための血漿カリクレイン阻害剤およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200317815A1 (https=) |
| EP (1) | EP3938404A1 (https=) |
| JP (2) | JP2022525164A (https=) |
| KR (1) | KR20210142006A (https=) |
| AU (1) | AU2020237259A1 (https=) |
| CA (1) | CA3133576A1 (https=) |
| MX (1) | MX2021011110A (https=) |
| TW (1) | TW202100561A (https=) |
| WO (1) | WO2020186132A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT201800552T1 (it) | 2010-01-06 | 2018-11-09 | Dyax Corp | Proteine che legano la callicreina plasmatica |
| KR102320178B1 (ko) | 2011-01-06 | 2021-11-02 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 결합 단백질 |
| AU2014240045A1 (en) | 2013-03-15 | 2015-09-10 | Dyax Corp. | Anti-plasma kallikrein antibodies |
| EA038532B1 (ru) | 2014-01-21 | 2021-09-10 | Такеда Фармасьютикал Компани Лимитед | Способ лечения наследственного ангионевротического отека (hae) |
| US10428158B2 (en) | 2014-03-27 | 2019-10-01 | Dyax Corp. | Compositions and methods for treatment of diabetic macular edema |
| EP3387018A1 (en) | 2015-12-11 | 2018-10-17 | Dyax Corp. | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
| EP4090427A1 (en) * | 2020-01-13 | 2022-11-23 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack |
| CN114790245A (zh) * | 2021-01-25 | 2022-07-26 | 成都康弘生物科技有限公司 | 一种抗体及其用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5374548A (en) | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| MX9203291A (es) | 1985-06-26 | 1992-08-01 | Liposome Co Inc | Metodo para acoplamiento de liposomas. |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US4881175A (en) | 1986-09-02 | 1989-11-14 | Genex Corporation | Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| WO1995021601A2 (en) | 1994-01-11 | 1995-08-17 | Protein Engineering Corporation | Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
| ES2348230T3 (es) | 2002-06-07 | 2010-12-01 | Dyax Corp. | Prevención y reducción de la isquemia. |
| EA038532B1 (ru) * | 2014-01-21 | 2021-09-10 | Такеда Фармасьютикал Компани Лимитед | Способ лечения наследственного ангионевротического отека (hae) |
| EP3387018A1 (en) * | 2015-12-11 | 2018-10-17 | Dyax Corp. | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
-
2020
- 2020-03-13 AU AU2020237259A patent/AU2020237259A1/en active Pending
- 2020-03-13 MX MX2021011110A patent/MX2021011110A/es unknown
- 2020-03-13 JP JP2021555282A patent/JP2022525164A/ja active Pending
- 2020-03-13 TW TW109108355A patent/TW202100561A/zh unknown
- 2020-03-13 KR KR1020217033056A patent/KR20210142006A/ko active Pending
- 2020-03-13 US US16/817,671 patent/US20200317815A1/en active Pending
- 2020-03-13 EP EP20718034.0A patent/EP3938404A1/en active Pending
- 2020-03-13 WO PCT/US2020/022535 patent/WO2020186132A1/en not_active Ceased
- 2020-03-13 CA CA3133576A patent/CA3133576A1/en active Pending
-
2025
- 2025-01-08 JP JP2025002888A patent/JP2025061116A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022525164A5 (https=) | ||
| JP2022033868A5 (https=) | ||
| JP2020002171A5 (https=) | ||
| RU2650618C2 (ru) | Комбинации и их применение | |
| JP2021535161A5 (https=) | ||
| JP2021514969A5 (https=) | ||
| JP2019523295A5 (https=) | ||
| JP2018514510A5 (https=) | ||
| JP2003531129A5 (https=) | ||
| JP2024113183A5 (https=) | ||
| WO2016180958A1 (en) | Treatment for multiple myeloma (mm) | |
| JP2023527542A5 (https=) | ||
| JP2023510854A5 (https=) | ||
| TWI870592B (zh) | 使用免疫檢查點抑制劑抗體治療癌症之方法和組合 | |
| JP2021523138A5 (https=) | ||
| JP2021532176A5 (https=) | ||
| JP2022514561A5 (https=) | ||
| TW202321303A (zh) | 抗pla2r自體抗體媒介膜性腎病變之治療 | |
| JP2024540435A5 (https=) | ||
| CN116209443A (zh) | 治疗小细胞肺癌的药物组合 | |
| JP2023546504A5 (https=) | ||
| JP2023544620A5 (https=) | ||
| JP2022547061A5 (https=) | ||
| RU2021129732A (ru) | Ингибиторы плазменного калликреина и их применение для лечения приступа наследственного ангионевротического отека | |
| JP2024522620A5 (https=) |